Inventor · disambiguated record
Yongxin Han
Also filed as: HAN YONGXIN
86 granted patents·31 pending applications·715 citations·filing 1996–2025
99Inventor score
Files withMERCK SHARP & DOHME32MERCK SHARP & DOHME LLC16CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD12CENTAURUS BIOPHARMA CO LTD8COLUCCI JOHN7
Top patents by PatentIndex Score
117 records- 0197US5698584A3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to COX-2 inhibitorsMERCK FROSST CANADA INC·Filed 1996·Granted Dec 16, 1997·138 cites·18 claims
- 0296US10189831B2Non-nucleoside reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Jan 29, 2019·75 cites·17 claims
- 0395US7179912B2Materials and methods to potentiate cancer treatmentLUITPOLD PHARM INC·Filed 2001·Granted Feb 20, 2007·79 cites·7 claims
- 0493US11697657B2Small molecule inhibitors of KRAS G12C mutantMERCK SHARP & DOHME LLC·Filed 2020·Granted Jul 11, 2023·4 cites·22 claims
- 0592US9725439B2Quinazoline derivative and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2014·Granted Aug 8, 2017·13 cites·16 claims
- 0691US6034089AAryl thiophene derivatives as PDE IV inhibitorsMERCK FROSST CANADA INC·Filed 1998·Granted Mar 7, 2000·72 cites·11 claims
- 0790US9926299B2Inhibitors of bruton's tyrosine kinaseCENTAURUS BIOPHARMA CO LTD·Filed 2013·Granted Mar 27, 2018·33 cites·9 claims
- 0887US8158671B2Indole and indoline cyclopropyl amide derivatives as EP4 receptor antagonistsBOYD MICHAEL·Filed 2008·Granted Apr 17, 2012·11 cites·8 claims
- 0987US6020339AAryl furan derivatives as PDE IV inhibitorsMERCK & CO INC·Filed 1998·Granted Feb 1, 2000·86 cites·9 claims
- 1085US9309211B2Arylalkene derivatives and use thereof as selective estrogen receptor modulatorsCENTAURUS BIOPHARMA CO LTD·Filed 2012·Granted Apr 12, 2016·11 cites·6 claims
- 1184US8987195B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 24, 2015·9 cites·27 claims
- 1283US10561657B2Pyrrolopyrimidine compoundCENTAURUS BIOPHARMA CO LTD·Filed 2015·Granted Feb 18, 2020·3 cites·19 claims
- 1383US7238710B2EP4 receptor agonist, compositions and methods thereofMERCK FROSST CANADA LTD·Filed 2005·Granted Jul 3, 2007·5 cites·11 claims
- 1483US6057319A3,4-Diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitorsMERCK FROSST CANADA INC·Filed 1996·Granted May 2, 2000·34 cites·20 claims
- 1582US12091405B2Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Sep 17, 2024·2 cites·13 claims
- 1682US9550781B2Kinase modulating compounds, compositions containing the same and use thereofCENTAURUS BIOPHARMA CO LTD·Filed 2012·Granted Jan 24, 2017·9 cites·14 claims
- 1781US12297208B2Small molecule inhibitors of KRAS G12C mutantMERCK SHARP & DOHME LLC·Filed 2023·Granted May 13, 2025·0 cites·18 claims
- 1881US12291538B2Small molecule inhibitors of KRAS G12C mutantMERCK SHARP & DOHME LLC·Filed 2023·Granted May 6, 2025·0 cites·6 claims
- 1981US12152019B2Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Nov 26, 2024·2 cites·20 claims
- 2081US10995085B2Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2020·Granted May 4, 2021·1 cites·12 claims
- 2181US10112922B2Inhibitor of bruton's tyrosine kinaseCENTAURUS BIOPHARMA CO LTD·Filed 2015·Granted Oct 30, 2018·4 cites·8 claims
- 2281US9469634B2Non-nucleoside reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Oct 18, 2016·3 cites·14 claims
- 2381US9328138B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted May 3, 2016·8 cites·17 claims
- 2481US8680114B2AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2009·Granted Mar 25, 2014·5 cites·20 claims
- 2581US8168815B2Fused aromatic PTP-1B inhibitorsCOLUCCI JOHN·Filed 2008·Granted May 1, 2012·4 cites·8 claims
- 2679US10745383B21,3,5-triazine derivative and method of using sameCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Aug 18, 2020·2 cites·15 claims
- 2779US10450309B2Aryl sulfonamides as BLT1 antagonistsMERCK SHARP & DOHME·Filed 2016·Granted Oct 22, 2019·2 cites·21 claims
- 2879US10336733B2Aryl acylsulfonamides as BLT1 antagonistsMERCK SHARP & DOHME·Filed 2016·Granted Jul 2, 2019·2 cites·20 claims
- 2976US7053085B2EP4 receptor agonist, compositions and methods thereofMERCK & CO INC·Filed 2004·Granted May 30, 2006·7 cites·10 claims
- 3075US6121253AProstaglandin conjugates for treating or preventing bone diseaseMERCK FROSST CANADA INC·Filed 1999·Granted Sep 19, 2000·36 cites·18 claims
- 3174US8003661B2Naphthalene and quinoline sulfonylurea derivatives as EP4 receptor antagonistsMERCK CANADA INC·Filed 2008·Granted Aug 23, 2011·2 cites·14 claims
- 3274US6699856B2Pyrazinones, compositions containing such compounds and methods of useMERCK FROSST CANADA INC·Filed 2002·Granted Mar 2, 2004·7 cites·16 claims
- 3374US6225288B1Gamma-ketoacid dipeptides as inhibitors of caspase-3MERK FROSST CANADA & CO·Filed 2000·Granted May 1, 2001·17 cites·14 claims
- 3473US9708295B2Substituted 2-aminopyridine protein kinase inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2014·Granted Jul 18, 2017·3 cites·17 claims
- 3573US8927526B2Fused aromatic PTP-1B inhibitorsCOLUCCI JOHN·Filed 2013·Granted Jan 6, 2015·1 cites·15 claims
- 3673US8013159B2Quinoline derivatives as EP4 antagonistsMERCK CANADA INC·Filed 2006·Granted Sep 6, 2011·2 cites·17 claims
- 3773USRE42562EEP4 receptor agonist, compositions and methods thereofMERCK FROSST CANADA·Filed 2007·Granted Jul 19, 2011·1 cites·20 claims
- 3871US8481742B2Fused aromatic PTP-1B inhibitorsCOLUCCI JOHN·Filed 2012·Granted Jul 9, 2013·1 cites·5 claims
- 3971US7109223B2Oxazolidin-2-one and thiazolidin-2-one derivatives for use as EP4 receptor agonists in the treatment of glaucomaMERCK & CO INC·Filed 2003·Granted Sep 19, 2006·5 cites·7 claims
- 4070US10570141B2Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Feb 25, 2020·1 cites·20 claims
- 4170US10336731B2Substituted 1H-indole-2-carboxamide compounds as indoleamine-2,3-dioxygenase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Jul 2, 2019·1 cites·11 claims
- 4270US9718819B2Non-nucleoside reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Aug 1, 2017·1 cites·19 claims
- 4370US7622482B2Chemical compoundsASTRAZENECA·Filed 2006·Granted Nov 24, 2009·1 cites·13 claims
- 4470US6444811B1Pyrazinones, compositions containing such compounds and methods of useMERCK FROSST CANADA INC·Filed 2000·Granted Sep 3, 2002·5 cites·1 claims
- 4568US6525025B2Gamma-ketoacid dipeptides as inhibitors of caspase-3MERCK FROSST CANADA INC·Filed 2001·Granted Feb 25, 2003·4 cites·22 claims
- 4667US10072003B2Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2015·Granted Sep 11, 2018·1 cites·8 claims
- 4767US9981946B2Pyridine-substituted 2-aminopyridine protein kinase inhibitorsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2015·Granted May 29, 2018·1 cites·20 claims
- 4866US12264139B2Aryl sulfonamides as BLT1 antagonistsMERCK SHARP & DOHME LLC·Filed 2021·Granted Apr 1, 2025·0 cites·18 claims
- 4964US8969394B2Thiophenecarboxamide derivatives as EP4 receptor ligandsBLOUIN MARC·Filed 2007·Granted Mar 3, 2015·1 cites·18 claims
- 5064US2009258918A1EP4 receptor agonist, compositions and methods thereofBILLOT XAVIER·Filed 2009·Application pending·0 cites
Showing the top 50 of 117 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yongxin Han files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →